Bono G - Search Results

1

Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type.

Martignoni E, Blandini F, Petraglia F, Pacchetti C, Bono G, Nappi G. Martignoni E, et al. Among authors: bono g. J Neural Transm Park Dis Dement Sect. 1992;4(3):191-205. doi: 10.1007/BF02260903. J Neural Transm Park Dis Dement Sect. 1992. PMID: 1320891

2

Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.

Martignoni E, Bono G, Blandini F, Sinforiani E, Merlo P, Nappi G. Martignoni E, et al. Among authors: bono g. J Neural Transm Park Dis Dement Sect. 1991;3(1):15-25. doi: 10.1007/BF02251133. J Neural Transm Park Dis Dement Sect. 1991. PMID: 1712206 Clinical Trial.

3

Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels.

Martignoni E, Petraglia F, Costa A, Bono G, Genazzani AR, Nappi G. Martignoni E, et al. Among authors: bono g. Acta Neurol Scand. 1990 May;81(5):452-6. doi: 10.1111/j.1600-0404.1990.tb00994.x. Acta Neurol Scand. 1990. PMID: 2375247

4

N-terminal ACTH fragments increase the CSF beta-EP content in Alzheimer type dementia.

Nappi G, Facchinetti F, Martignoni E, Petraglia F, Sinforiani E, Bono G, Genazzani AR. Nappi G, et al. Among authors: bono g. Acta Neurol Scand. 1988 Aug;78(2):146-51. doi: 10.1111/j.1600-0404.1988.tb03636.x. Acta Neurol Scand. 1988. PMID: 2845700

5

Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease.

Blandini F, Nappi G, Fancellu R, Mangiagalli A, Samuele A, Riboldazzi G, Calandrella D, Pacchetti C, Bono G, Martignoni E. Blandini F, et al. Among authors: bono g. J Neural Transm (Vienna). 2003 Aug;110(8):911-22. doi: 10.1007/s00702-003-0004-z. J Neural Transm (Vienna). 2003. PMID: 12898346

6

The brain as a target for adrenocortical steroids: cognitive implications.

Martignoni E, Costa A, Sinforiani E, Liuzzi A, Chiodini P, Mauri M, Bono G, Nappi G. Martignoni E, et al. Among authors: bono g. Psychoneuroendocrinology. 1992 Aug;17(4):343-54. doi: 10.1016/0306-4530(92)90040-e. Psychoneuroendocrinology. 1992. PMID: 1332100 Review.

7

beta-Endorphin cerebrospinal fluid decrease in untreated parkinsonian patients.

Nappi G, Petraglia F, Martignoni E, Facchinetti F, Bono G, Genazzani AR. Nappi G, et al. Among authors: bono g. Neurology. 1985 Sep;35(9):1371-4. doi: 10.1212/wnl.35.9.1371. Neurology. 1985. PMID: 2991818

8

An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics.

Costa A, Bono G, Martignoni E, Merlo P, Sances G, Nappi G. Costa A, et al. Among authors: bono g. Psychoneuroendocrinology. 1996 Apr;21(3):263-75. doi: 10.1016/0306-4530(96)00001-7. Psychoneuroendocrinology. 1996. PMID: 8817725 Clinical Trial.

9

Combined response of plasma and platelet catecholamines to different types of short-term stress.

Blandini F, Martignoni E, Sances E, Bono G, Nappi G. Blandini F, et al. Among authors: bono g. Life Sci. 1995 Feb 17;56(13):1113-20. doi: 10.1016/0024-3205(95)00048-b. Life Sci. 1995. PMID: 9001445 Clinical Trial.

10

Memory impairment in Cushing's disease.

Mauri M, Sinforiani E, Bono G, Vignati F, Berselli ME, Attanasio R, Nappi G. Mauri M, et al. Among authors: bono g. Acta Neurol Scand. 1993 Jan;87(1):52-5. doi: 10.1111/j.1600-0404.1993.tb04075.x. Acta Neurol Scand. 1993. PMID: 8424312

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters